Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Prodia Diagnostic Line Tbk (PRDL) vs Kian Santang Muliatama Tbk. (RGAS) Price & Performance

Prodia Diagnostic Line TbkTrade
Kian Santang Muliatama Tbk.Trade

Price performance (Past 24H)

Key statistics

Prodia Diagnostic Line Tbk vs Kian Santang Muliatama Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume), while Kian Santang Muliatama Tbk. trades at Rp189 (market cap 277.25B, 7.9M 24h volume). The key difference: Prodia Diagnostic Line Tbk is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (18.86M versus 7.9M). Which is the better fit depends on your goals.

PRDLRGAS
Market Cap
470.58B277.25B
Volume
18.86M7.9M
Lot
188.57K79K
Turnover
4.97B1.5B
Average Price
263.63189.43
Value
4.97B1.5B
Indicative Equilibrium Price
264189
Indicative Equilibrium Volume
3.64K13.98K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PRDL
View details
RGAS
View details

About Prodia Diagnostic Line Tbk

PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.

Read more on PRDL

About Kian Santang Muliatama Tbk.

PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.

Read more on RGAS